- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on NSCLC Adenocarcinoma
Total 10407 results
-
Olfred HansenOdense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Herlev Hospital and other collaboratorsRecruiting
-
Xinqiao Hospital of ChongqingCompleted
-
InventisBio Co., LtdActive, not recruiting
-
Allist Pharmaceuticals, Inc.Withdrawn
-
Klinikum Bayreuth GmbHPeking University Cancer Hospital & Institute; Sana Klinikum HofCompleted
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of Sheffield; Weston Park Hospital Cancer Charity; Sheffield Hospitals...Completed
-
Fudan UniversityCompleted
-
Sun Yat-sen UniversityUnknown
-
Chang Gung Memorial HospitalUnknown
-
Centre Hospitalier Saint Joseph Saint Luc de LyonCompletedPrevalence of Pancreas AdenocarcinomasFrance
-
Shanghai Kechow Pharma, Inc.Terminated
-
BiocadUnknownMelanoma | Renal Cell Carcinoma | NSCLC | Bladder CancerRussian Federation
-
Kyowa Kirin Korea Co., Ltd.TerminatedPhase 1 Portion : Non Small Cell Lung Cancer(NSCLC), Small Cell Lung Cancer(SCLC), Mesothelioma | Phase 2 Portion : Small Cell Lung Cancer(SCLC)Korea, Republic of
-
The First Affiliated Hospital with Nanjing Medical...RecruitingMetastatic NSCLC | Recurrent NSCLC | Advanced Non-Small Cell Squamous Lung CancerChina
-
University Hospital, Strasbourg, FranceNot yet recruiting
-
Shenzhen People's HospitalUnknownNSCLC | Apatinib | EGFR-TKIChina
-
Instituto Oncológico Dr RosellTurning Point Therapeutics, Inc.Recruiting
-
PTS International Inc.Completed
-
Sunshine Lake Pharma Co., Ltd.Not yet recruiting
-
Lung Cancer Group CologneTerminatedNSCLC | Lung Cancer | NSCLC Stage IV | Squamous Cell Lung Cancer | Pulmonary NeoplasmGermany
-
Qilu Hospital of Shandong UniversityUnknown
-
University Hospital, Strasbourg, FranceRecruitingGastric and Cardia AdenocarcinomasFrance
-
Shenzhen People's HospitalUnknown
-
Regeneron PharmaceuticalsRecruiting
-
Spectrum Pharmaceuticals, IncTerminatedBreast Cancer | NSCLCUnited States
-
Samsung Medical CenterUnknownSquamous NSCLCKorea, Republic of
-
AstraZenecaCompleted
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Newsoara Biopharma Co., Ltd.Not yet recruiting
-
Fujian Cancer HospitalNot yet recruiting
-
University Hospital, EssenRecruiting
-
Zhejiang Genfleet Therapeutics Co., Ltd.Active, not recruiting
-
Michael HoppBoehringer IngelheimActive, not recruiting
-
Peking University Cancer Hospital & InstituteEnrolling by invitationLocally Advanced NSCLCChina
-
Sichuan UniversityInnovent Biologics (Suzhou) Co. Ltd.Completed
-
Shenzhen People's HospitalEnrolling by invitation
-
Yonsei UniversityWithdrawn
-
Kiang Wu HospitalCompleted
-
Agenus Inc.Terminated
-
AstraZenecaUnknownNSCLC Patient CharacteristicsSaudi Arabia
-
Stanford UniversityTerminatedLung Cancer | Mesothelioma | Lung Cancer Non-Small Cell Cancer (NSCLC) | Lung Cancer Small Cell Lung Cancer (SCLC)United States
-
ETOP IBCSG Partners FoundationTakedaRecruitingNSCLC, Stage III | ALK-rearrangementFrance, Spain, Italy, Poland, United Kingdom
-
IO BiotechMerck Sharp & Dohme LLCCompletedNSCLCUnited Kingdom, Germany, Netherlands, Spain
-
Maastricht Radiation OncologyUniversity of Pennsylvania; University of Wisconsin, MadisonCompleted
-
German Cancer Research CenterUniversity Hospital Heidelberg; National Center for Tumor Diseases, HeidelbergCompleted
-
Fujian Cancer HospitalUnknownChemotherapy Effect | NSCLC Stage IVChina
-
AstraZenecaNo longer available
-
Shandong Cancer Hospital and InstituteRecruitingUnresectable Stage III NSCLCChina
-
Molecular Partners AGTerminatedEGFR-mutated NSCLC (Disorder)United States